Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Compares same-day discharge with an overnight stay after weight-loss surgery

Tests going home the same day versus staying overnight after weight-loss surgery in adults.

Plain-language title generated from the registry record
Registry title: Transition to Ambulatory Bariatric Surgery (TABS) Trial

Key facts

Where
Nashville, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 25 and 55 years old?

Source: NCT07011628, who can take part

Where in United States

  • Vanderbilt University Medical CenterNashville, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Vanderbilt University Medical Center
Trial code
NCT07011628
Record updated
21 September 2026
Original description
This study will compare same day discharge and at least one night stay in the hospital after bariatric surgery. Patients undergoing bariatric surgery will be randomized (i.e. have an equal chance of either plan) to either group. The study's primary outcome is the frequency patients in the study require a visit to the emergency room within 7 days of their surgery.Read full original descriptionShow less

Transition to Ambulatory Bariatric Surgery (TABS) Trial

This study will compare same day discharge and at least one night stay in the hospital after bariatric surgery. Patients undergoing bariatric surgery will be randomized (i.e. have an equal chance of either plan) to either group. The study's primary outcome is the frequency patients in the study require a visit to the emergency room within 7 days of their surgery.

Inclusion: BMI ≤ 60 kg/m2; Primary Sleeve gastrectomy or Gastric Bypass,; Undergoing bariatric surgery at sponsor site.

Exclusion: Prior Stroke; Solid organ transplantation; Systemic glucocorticoid prior 28 days; > 1 lifetime bariatric surgery (revisional or conversion bariatric surgery); Type 1 Diabetes; Myocardial Infarction; Unstable Angina or Heart Failure; Uncontrolled Hypertension (Systolic > 150, Diastolic > 90); Chronic Kidney Disease (EGFR < 60); Poorly controlled Type 2 diabetes (Hemoglobin A1c in last 3 months > 8.5%); Severe Obstructive Sleep Apnea; Untreated Hyperthyroidism; Current anticoagulant use,; Chronic opioid use; Insulin dependence; Need for extended venous thromboembolic event prophylaxis,; Patient lives > 130 miles from the hospital; Tobacco use in last 12 months; Desire to become pregnant or active pregnancy; Prisoners; Unable or unwilling to follow-up; Unable to understand or provide consent.

ClinicalTrials.gov NCT07011628